IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,059,683 | +1218.8% | 79,700 | +84.5% | 0.00% | – |
| Q3 2022 | $232,000 | -3.3% | 43,200 | -26.8% | 0.00% | – |
| Q2 2022 | $240,000 | -25.0% | 59,000 | +1.5% | 0.00% | – |
| Q1 2022 | $320,000 | -31.3% | 58,100 | +4.1% | 0.00% | -100.0% |
| Q4 2021 | $466,000 | -32.1% | 55,800 | -28.3% | 0.00% | 0.0% |
| Q3 2021 | $686,000 | -46.4% | 77,800 | -34.4% | 0.00% | -50.0% |
| Q2 2021 | $1,281,000 | +109.7% | 118,600 | +191.4% | 0.00% | +100.0% |
| Q1 2021 | $611,000 | – | 40,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |